Category: Health News

Mikhail Blagosklonny: The Science & Passion in Healing

Mikhail Blagosklonny is an oncologist, and one of the best professionals in the area right now.Oncology is the study of treatment of tumors. The prevention, diagnosis, and treatment of cancer is the primary research field of this partition.Mikhail, being one of the most prominent oncologists in the world, is also a philanthropist and a scientist, meaning that, besides being a researcher and professor on oncology, he can also do his other passion, which is to help people in need.Mikhail Blagosklonny is aware of the fact that current cancer treatments are expensive and can only be afforded by rich individuals. Mikhail’s plan for oncology is to develop cancer treatments that would not only be efficient but also inexpensive, and therefore being able to be afforded by everyone regardless of financial status. Cancer is one of the most tragic and deadly diseases in the world, and it is unfortunate that if you are poor, chances are you won’t be able to afford any treatment for it. Mikhail is determined to change that by tirelessly researching ways to cure cancer.

One of the most interesting topics of Mikhail Blagosklonny’s research is the famous Rapamycin. When a person undergoes an organ transplant, the most common danger is that the individual’s body might reject the new organ as it is recognized as a “foreign” substance. The immune system works that way. It targets any foreign substance that goes through our body. Rapamycin is a drug that prevents this kind of “rejection” by the body.Mikhail is conducting research not only on cancer but on aging, and he also considers Rapamycin as a wonder drug, meaning that it has many more utilities than what medicine has found until now. His anti-aging drug is one of the most researched topics on Oncology on the internet, and it is one of the most promising studies in that field that has tremendous potential to change the future.Rapamycin is the primary drug approved for curing Lymphangioleiomyomatosis (LAM). LAM is a very rare lung disease that affects women.

What LAM does is activating the mTOR signaling gateway by infiltrating the lung tissue using Tuberous Sclerosis Complex gene mutations. Lymphangiogenic growth factors are released because of this, but Rapamycin blocks the gateway. Rapamycin is a popular immunosuppressant drug, as explained with the organ rejection trait that it contains. But it is also a popular antiproliferative drug, meaning Rapamycin can help treat cancer in two ways. First, if the cancer patient needs of an organ transplant, Rapamycin is used to make sure that his or her body accepts the new organ. Second, Rapamycin’s antiproliferative properties prevent cancer cells to proliferate in the body, and not only that, but Rapamycin can also boost the body’s immune system in fighting tumors as well as hasten its regression.  All of these properties and many others make Rapamycin the world’s best drug that you’ve never heard about, and thanks to the continuous research of Mikhail Blagosklonny, more and more uses for this wonder drug will be discovered.

Dr. Sergio Cortes Weighs in On Zika Virus after Mother’s Complaint of Neglect by State

Marilia Lima is a frustrated woman. Holding her two and half month’s old Zika virus affected child, Lima painfully expresses her disgust with the government for neglect. Her son, Arthur, is one of the more than 3,500 children all over Brazil that were born with microcephaly, a condition inhibiting natural child development, in the course of this year. Her bitterness arises from the feeling that her child and many others across Brazil are suffering and there is nothing she can do about it while the government doesn’t act concerned.
Lima lives in the northeastern part of the country and the numerous trips she has been making to and from the local child care center don’t seem to be yielding. She says there has been no followup towards her case and neither are the doctors at the facility of much help. Given that this is a new disease, they don’t seem to know much about the disease. The facility also can’t seem to hold the pressure of the number of children affected and the government seems reluctant with allocations.
About the Virus
Dr. Sergio Cortes, a long time physician and secretary to the Rio de Janeiro state health department, weighs in on the Zika virus scare explaining its origin and symptoms. According to an article on National Public Radio he published on his sergiocortesofficial website, Sergio traces the origin of the Zika virus that causes the microcephaly condition in infants whose mothers are affected by the virus while pregnant. He further says that the virus is transmitted by mosquitos but is quick to differentiate it from a similar viral disease, Dengue, that has been plaguing Brazil for quite some time.
Sergio points out that the Zika virus and its effects are new to Brazil and the entire Latin America. He indicates that the virus was first discovered in the central parts of Africa especially in Uganda and Sierra Leone and only reached Latin America in early 2015. Nevertheless, he acknowledges its outbreak and the need for cautiousness for Brazilian people living near water bodies as he confirms that the virus is mosquito-transmitted.
In one of his other post on his website that he regularly updates on different topics revolving around health,Sergio educates on how to differentiate between the Zika and Dengue viruses. Sergio is quite conversant with these two viruses not just because of his experience but because he served as the state secretary for health when Dengue virus first struck Rio.
He notes that apart from the striking similarities these two diseases share including high fever, body and muscle aches they have some differences. He notes that the most obvious symptom between the two is that while dengue results in severe pains behind the eyes, Zika is more associated with itching in the eye cup and red eyes. Sergio is regularly advising on such and other diseases through his social media sites and can be followed on twitter as well as LinkedIn.